Plunkett Research Online: Omeros Corp

OMEROS CORP (OMER:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The company’s most clinically advanced product candidates are derived from its proprietary PharmacoS.....



Omeros Corp
Ticker: OMER
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 206 676-5000
Fax: 206 676-5005
Address: 201 Elliott Avenue West
Seattle, WA 98119 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Biopharmaceutical Discovery & Development
ContactsDescription
Gregory DemopulosCEO/Chairman of the Board/Director/Founder/President
J. WhitakerChief Medical Officer/Vice President, Divisional
See More
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The company’s most clinically advanced product candidates are derived from its proprietary PharmacoS.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Wilson, Sonsini, Goodrich & Rosati
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: